| CASE REPORT |
|
| Year : 2017 | Volume
: 1
| Issue : 2 | Page : 127-128 |
|
|
Fluvoxamine-induced reversible euprolactinemic galactorrhea in a case of obsessive-compulsive disorder
Chetan Dilip Vispute1, Shubhangi R Parkar2, Deepika A Singh3
1 Department of Psychiatry, MGM Medical College and Hospital, Mumbai, Maharashtra, India
2 Department of Psychiatry, Bombay Drug Deaddiction Center, Seth GS Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India
3 Department of Psychiatry, NKP Salve Institute of Medical Sciences, Nagpur, Maharashtra, India
Correspondence Address:
Chetan Dilip Vispute
Department of Psychiatry, MGM Medical College and Hospital, Navi Mumbai - 410 209, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | 5 |
DOI: 10.4103/aip.aip_18_17
|
|
|
Fluvoxamine is one of the commonly used selective serotonin reuptake inhibitors (SSRIs) as a first-line treatment for obsessive-compulsive disorder (OCD). Galactorrhea is a rarely observed adverse effect of SSRIs occurring through complex interactions between serotonergic and dopaminergic systems of brain. We report a case of fluvoxamine-induced reversible euprolactinemic galactorrhea in a 39-year-old woman after initiation of fluvoxamine for OCD. The patient's galactorrhea resolved on discontinuation of fluvoxamine.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
